Abstract
Purpose
Deciding whether patients with a cytologically indeterminate thyroid nodule should be referred for surgery or for active surveillance is an important challenge for clinicians. The aim of this study was to evaluate the performance of a novel dual-component molecular assay as an ancillary molecular method for resolving indeterminate thyroid nodule cytology.
Methods
We selected 156 thyroid nodules from those that had undergone fine-needle aspiration processed by liquid-based cytology and surgical resection between June 2016 and December 2017. The sample set included 63 nodules cytologically classified as indeterminate, and 93 other nodules randomly selected from those with non-diagnostic, benign, suspicious, or malignant cytology. Nucleic acids from each nodule were subjected to next-generation sequencing analysis for mutation detection in 23 genes and to digital polymerase chain reaction (PCR) evaluation for miR-146b-5p expression levels.
Results
Used alone, mutation analysis in the indeterminate subset (cancer prevalence: 22.5%) displayed high sensitivity (89%) and NPV (96%). In contrast, the miR-146b-5p assay offered high specificity (93%) and PPV (93%). Combined use of both analyses improved panel performance by eliminating false-negative results.
Conclusions
These preliminary data suggest that a dual-component molecular test can increase the diagnostic accuracy of thyroid cytology alone by reducing the number of nodules that will be classified as indeterminate and increasing those that can be reliably classified as benign. If these findings are confirmed, this test can be considered for use in clinical practice and is expected to reduce diagnostic surgery and health care costs, and to improve patient quality of life.
Similar content being viewed by others
References
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016). https://doi.org/10.1089/thy.2015.0020
C. Durante, G. Grani, L. Lamartina, S. Filetti, S.J. Mandel, D.S. Cooper, The diagnosis and management of thyroid nodules: a review. JAMA 319, 914–924 (2018). https://doi.org/10.1001/jama.2018.0898
M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 56, 333–339 (2012). https://doi.org/10.1159/000339959
E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. J. Am. Soc. Cytopathol. 6, 217–222 (2017). https://doi.org/10.1016/j.jasc.2017.09.002
Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, P. Vielh, R.M. DeMay, M.K. Sidawy, W.J. Frable, Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn. Cytopathol. 36, 425–437 (2008). https://doi.org/10.1002/dc.20830
N. Agrawal, R. Akbani, B.A. Aksoy, A. Ally, H. Arachchi, S.L. Asa, J.T. Auman, M. Balasundaram, S. Balu, S.B. Baylin, M. Behera, B. Bernard, R. Beroukhim, J.A. Bishop, A.D. Black, T. Bodenheimer, L. Boice, M.S. Bootwalla, J. Bowen, R. Bowlby, C.A. Bristow, R. Brookens, D. Brooks, R. Bryant, E. Buda, Y.S.N. Butterfield, T. Carling, R. Carlsen, S.L. Carter, S.E. Carty, T.A. Chan, A.Y. Chen, A.D. Cherniack, D. Cheung, L. Chin, J. Cho, A. Chu, E. Chuah, K. Cibulskis, G. Ciriello, A. Clarke, G.L. Clayman, L. Cope, J.A. Copland, K. Covington, L. Danilova, T. Davidsen, J.A. Demchok, D. DiCara, N. Dhalla, R. Dhir, S.S. Dookran, G. Dresdner, J. Eldridge, G. Eley, A.K. El-Naggar, S. Eng, J.A. Fagin, T. Fennell, R.L. Ferris, S. Fisher, S. Frazer, J. Frick, S.B. Gabriel, I. Ganly, J. Gao, L.A. Garraway, J.M. Gastier-Foster, G. Getz, N. Gehlenborg, R. Ghossein, R.A. Gibbs, T.J. Giordano, K. Gomez-Hernandez, J. Grimsby, B. Gross, R. Guin, A. Hadjipanayis, H.A. Harper, D.N. Hayes, D.I. Heiman, J.G. Herman, K.A. Hoadley, M. Hofree, R.A. Holt, A.P. Hoyle, F.W. Huang, M. Huang, C.M. Hutter, T. Ideker, L. Iype, A. Jacobsen, S.R. Jefferys, C.D. Jones, S.J.M. Jones, K. Kasaian, E. Kebebew, F.R. Khuri, J. Kim, R. Kramer, R. Kreisberg, R. Kucherlapati, D.J. Kwiatkowski, M. Ladanyi, P.H. Lai, P.W. Laird, E. Lander, M.S. Lawrence, D. Lee, E. Lee, S. Lee, W. Lee, K.M. Leraas, T.M. Lichtenberg, L. Lichtenstein, P. Lin, S. Ling, J. Liu, W. Liu, Y. Liu, V.A. LiVolsi, Y. Lu, Y. Ma, H.S. Mahadeshwar, M.A. Marra, M. Mayo, D.G. McFadden, S. Meng, M. Meyerson, P.A. Mieczkowski, M. Miller, G. Mills, R.A. Hadjipanayis, L.E. Mose, A.J. Mungall, B.A. Murray, Y.E. Nikiforov, M.S. Noble, A.I. Ojesina, T.K. Owonikoko, B.A. Ozenberger, A. Pantazi, M. Parfenov, P.J. Park, J.S. Parker, E.O. Paull, C.S. Pedamallu, C.M. Perou, J.F. Prins, A. Protopopov, S.S. Ramalingam, N.C. Ramirez, R. Ramirez, B.J. Raphael, W.K. Rathmell, X. Ren, S.M. Reynolds, E. Rheinbay, M.D. Ringel, M. Rivera, J. Roach, A.G. Robertson, M.W. Rosenberg, M. Rosenthal, S. Sadeghi, G. Saksena, C. Sander, N. Santoso, J.E. Schein, N. Schultz, S.E. Schumacher, R.R. Seethala, J. Seidman, Y. Senbabaoglu, S. Seth, S. Sharpe, K.R.M. Shaw, J.P. Shen, R. Shen, S. Sherman, M. Sheth, Y. Shi, I. Shmulevich, G.L. Sica, J.V. Simons, R. Sinha, P. Sipahimalani, R.C. Smallridge, H.J. Sofia, M.G. Soloway, X. Song, C. Sougnez, C. Stewart, P. Stojanov, J.M. Stuart, S.O. Sumer, Y. Sun, B. Tabak, A. Tam, D. Tan, J. Tang, R. Tarnuzzer, B.S. Taylor, N. Thiessen, L. Thorne, V. Thorsson, R.M. Tuttle, C.B. Umbricht, D.J. Van Den Berg, F. Vandin, U. Veluvolu, R.G.W. Verhaak, M. Vinco, D. Voet, V. Walter, Z. Wang, S. Waring, P.M. Weinberger, N. Weinhold, J.N. Weinstein, D.J. Weisenberger, D. Wheeler, M.D. Wilkerson, J. Wilson, M. Williams, D.A. Winer, L. Wise, J. Wu, L. Xi, A.W. Xu, L. Yang, L. Yang, T.I. Zack, M.A. Zeiger, D. Zeng, J.C. Zenklusen, N. Zhao, H. Zhang, J. Zhang, J.(Julia) Zhang, W. Zhang, E. Zmuda, L. Zou, Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2015). https://doi.org/10.1016/j.cell.2014.09.050
I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly-differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052–1066 (2016). https://doi.org/10.1172/JCI85271
C. Ferraz, Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB? Arch. Endocrinol. Metab. 62, 576–584 (2018). https://doi.org/10.20945/2359-3997000000081
F. Nardi, F. Basolo, A. Crescenzi, G. Fadda, A. Frasoldati, F. Orlandi, L. Palombini, E. Papini, M. Zini, A. Pontecorvi, P. Vitti, Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37, 593–599 (2014). https://doi.org/10.1007/s40618-014-0062-0
E.S. Cibas, S.Z. Ali, The 2017 Bethesda system for reporting thyroid cytopathology. J. Am. Soc. Cytopathol. 6, 217–222 (2017). https://doi.org/10.1016/j.jasc.2017.09.002
M. Sponziello, S. Benvenuti, A. Gentile, V. Pecce, F. Rosignolo, A.R. Virzì, M. Milan, P.M. Comoglio, E. Londin, P. Fortina, A. Barnabei, M. Appetecchia, F. Marandino, D. Russo, S. Filetti, C. Durante, A. Verrienti, Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. Hum. Mutat. 39, 371–377 (2018). https://doi.org/10.1002/humu.23378
M. Sponziello, G. Silvestri, A. Verrienti, A. Perna, F. Rosignolo, C. Brunelli, V. Pecce, E.D. Rossi, C.P. Lombardi, C. Durante, S. Filetti, G. Fadda, A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma. Endocrine 62, 492–495 (2018)
L.M. Mulligan, Exploiting insights on the RET receptor for personalized cancer medicine. Endocr. Relat. Cancer. 25, T189–T200 (2018). https://doi.org/10.1530/ERC-18-0141
Y.E. Nikiforov, Role of molecular markers in thyroid nodule management: then and now. Endocr. Pract. 23, 979–988 (2017). https://doi.org/10.4158/EP171805.RA
F. Rosignolo, L. Memeo, F. Monzani, C. Colarossi, V. Pecce, A. Verrienti, C. Durante, G. Grani, L. Lamartina, S. Forte, D. Martinetti, D. Giuffrida, D. Russo, F. Basolo, S. Filetti, M. Sponziello, MicroRNA-based molecular classification of papillary thyroid carcinoma. Int. J. Oncol. 50, 1767–1777 (2017). https://doi.org/10.3892/ijo.2017.3960
F. Rosignolo, M. Sponziello, L. Giacomelli, D. Russo, V. Pecce, M. Biffoni, R. Bellantone, C.P. Lombardi, L. Lamartina, G. Grani, C. Durante, S. Filetti, A. Verrienti, Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up. J. Endocr. Soc. 1, 3–13 (2017). https://doi.org/10.1210/js.2016-1032
M. Celano, F. Rosignolo, V. Maggisano, V. Pecce, M. Iannone, D. Russo, S. Bulotta, MicroRNAs as biomarkers in thyroid carcinoma. Int. J. Genomics 2017, 6496570 (2017). https://doi.org/10.1155/2017/6496570
G. Grani, L. Lamartina, V. Ascoli, D. Bosco, F. Nardi, F. D’Ambrosio, A. Rubini, L. Giacomelli, M. Biffoni, S. Filetti, C. Durante, V. Cantisani, Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules. Endocrine 57, 256–261 (2017). https://doi.org/10.1007/s12020-016-1148-6
P. Valderrabano, M.J. McGettigan, C.A. Lam, L. Khazai, Z.J. Thompson, C.H. Chung, B.A. Centeno, B. McIver, Thyroid nodules with indeterminate cytology: utility of the American Thyroid Association sonographic patterns for cancer risk stratification. Thyroid 28, 1004–1012 (2018). https://doi.org/10.1089/thy.2018.0085
T. Rago, M. Scutari, F. Santini, V. Loiacono, P. Piaggi, G. Di Coscio, F. Basolo, P. Berti, A. Pinchera, P. Vitti, Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J. Clin. Endocrinol. Metab. 95, 5274–5280 (2010). https://doi.org/10.1210/jc.2010-0901
V. Cantisani, E. David, H. Grazhdani, A. Rubini, M. Radzina, C.F. Dietrich, C. Durante, L. Lamartina, G. Grani, A. Valeria, D. Bosco, C. Di Gioia, F.M. Frattaroli, V. D’Andrea, C. De Vito, D. Fresilli, F. D’Ambrosio, L. Giacomelli, C. Catalano, Prospective evaluation of semiquantitative strain ratio and quantitative 2D ultrasound shear wave elastography (SWE) in association with TIRADS classification for thyroid nodule characterization. Ultraschall Med. 40, 495–503 (2019). https://doi.org/10.1055/a-0853-1821
F. Ianni, D. Pascucci, R.M. Paragliola, C.A. Rota, G. Perotti, G. Fadda, A. Pontecorvi, S.M. Corsello, Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision making in the preoperative assessment? Thyroid 30, 65–71 (2019). https://doi.org/10.1089/thy.2018.0649
Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41–44 (2002). https://doi.org/10.1002/dc.10043
R. Promberger, J. Ott, F. Kober, M. Karik, M. Freissmuth, M. Hermann, Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy. Thyroid 21, 145–150 (2011). https://doi.org/10.1089/thy.2010.0067
E. Kandil, B. Krishnan, S.I. Noureldine, L. Yao, R.P. Tufano, Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL 75, 6–17 (2013). https://doi.org/10.1159/000345498
J.A. Sosa, H.M. Bowman, J.M. Tielsch, N.R. Powe, T.A. Gordon, R. Udelsman, The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann. Surg. 228, 320–330 (1998). https://doi.org/10.1097/00000658-199809000-00005
H. Verloop, M. Louwerens, J.W. Schoones, J. Kievit, J.W.A. Smit, O.M. Dekkers, Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J. Clin. Endocrinol. Metab. 97, 2243–2255 (2012). https://doi.org/10.1210/jc.2012-1063
S. Filetti, P.W. Ladenson, M. Biffoni, M.G. D’Ambrosio, L. Giacomelli, S. Lopatriello, The true cost of thyroid surgery determined by a micro-costing approach. Endocrine 55, 519–529 (2017). https://doi.org/10.1007/s12020-016-0980-z
K.N. Patel, T.E. Angell, J. Babiarz, N.M. Barth, T. Blevins, Q.-Y. Duh, R.A. Ghossein, R.M. Harrell, J. Huang, G.C. Kennedy, S.Y. Kim, R.T. Kloos, V.A. LiVolsi, G.W. Randolph, P.M. Sadow, M.H. Shanik, J.A. Sosa, S.T. Traweek, P.S. Walsh, D. Whitney, M.W. Yeh, P.W. Ladenson, Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surg. 153, 817–824 (2018). https://doi.org/10.1001/jamasurg.2018.1153
Y.E. Nikiforov, D.L. Steward, S.E. Carty, R.S. Sippel, S.P. Yang, J.A. Sosa, J.A. Sipos, J.J. Figge, S. Mandel, B.R. Haugen, K.D. Burman, Z.W. Baloch, R.V. Lloyd, R.R. Seethala, W.E. Gooding, S.I. Chiosea, C. Gomes-Lima, R.L. Ferris, J.M. Folek, R.A. Khawaja, P. Kundra, K.S. Loh, C.B. Marshall, S. Mayson, K.L. McCoy, M.E. Nga, K.Y. Ngiam, M.N. Nikiforova, J.L. Poehls, M.D. Ringel, H. Yang, L. Yip, Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study. JAMA Oncol. 5, 204–212 (2019). https://doi.org/10.1001/jamaoncol.2018.4616
M.N. Nikiforova, S. Mercurio, A.I. Wald, M. Barbi de Moura, K. Callenberg, L. Santana-Santos, W.E. Gooding, L. Yip, R.L. Ferris, Y.E Nikiforov, Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 124, 1682–1690 (2018). https://doi.org/10.1002/cncr.31245
E. Labourier, A. Shifrin, A.E. Busseniers, M.A. Lupo, M.L. Manganelli, B. Andruss, D. Wylie, S. Beaudenon-Huibregtse, Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology. J. Clin. Endocrinol. Metab. 100, 2743–2750 (2015). https://doi.org/10.1210/jc.2015-1158
A.B. Banizs, J.F. Silverman, The utility of combined mutation analysis and microRNA classification in reclassifying cancer risk of cytologically indeterminate thyroid nodules. Diagn. Cytopathol. 47, 268–274 (2019). https://doi.org/10.1002/dc.24087
G. Lithwick-Yanai, N. Dromi, A. Shtabsky, S. Morgenstern, Y. Strenov, M. Feinmesser, V. Kravtsov, M.E. Leon, M. Hajdúch, S.Z. Ali, C.J. VandenBussche, X. Zhang, L. Leider-Trejo, A. Zubkov, S. Vorobyov, M. Kushnir, Y. Goren, S. Tabak, E. Kadosh, H. Benjamin, T. Schnitzer-Perlman, H. Marmor, M. Motin, D. Lebanony, S. Kredo-Russo, H. Mitchell, M. Noller, A. Smith, O. Dattner, K. Ashkenazi, M. Sanden, K.A. Berlin, D. Bar, E. Meiri, Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. J. Clin. Pathol. 70, 500–507 (2017). https://doi.org/10.1136/jclinpath-2016-204089
Acknowledgements
The study was supported by Ministero dell'Istruzione, dell'Università e della Ricerca, Italy (MIUR, investigator grant 2015 project code PRIN 2015HPMLFY to C.D.), the “Sapienza” University of Rome (grant RM11715C7DD0EF56 to S.F. and RP11916B8919C921 to M.S.), Friuli Venezia Giulia (grant POR FESR PREDITT to G.D.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures involving humans were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Written informed consent was obtained from all subjects included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sponziello, M., Brunelli, C., Verrienti, A. et al. Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules. Endocrine 68, 458–465 (2020). https://doi.org/10.1007/s12020-020-02271-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02271-y